Articles
-
Read External ArticleA now-or-never moment for telehealth?
Our CMO Dr. Andrew Hertler speaks with HFMA about the role of telehealth in oncology care today.
-
Read ArticleTraditional UM Programs Can't Move the Needle in Cardiology Care. Here's What Does.
Senior Medical Director Fernando Villacian lays out the key tenets of an effective cardiovascular management program.
-
Read External ArticleCardiovascular Clinical Pathways Program at New Century Health
Our senior medical director speaks with Journal of Clinical Pathways about preventing inappropriate use in cardiology.
-
Read ArticleNew Century Health Reports Year of Record Growth and Clinical Innovation in 2020
New Century Health announced that 2020 was the largest membership growth year in the 19-year history of the company.
-
Read ArticleCan Clinical Pathways Help Combat Health Care Disparities?
A new research effort aims to gauge whether certain groups of patients receive high-value therapies at lower rates than others.
-
Read ArticleA Redesigned Prior Authorization is Needed in Oncology. Here's How.
Payer strains now top the list of stressors facing oncologists, with prior authorization as the most-cited source of that payer stress.
-
Read ArticleEvolent Health, Parent Company of New Century Health, Names Kim Keck To Board of Directors
Evolent Health, Parent Company of New Century Health, Names Kim Keck to Board of Directors. Announces Cheryl Scott to Serve as Lead Independent Director.
-
Read ArticlePathways, Portals and Persuasion: Reining in an Overused Cancer Agent
NCH's approach to more appropriate use of myeloid growth factor provides a playbook for how to change prescribing patterns.
-
Read ArticleExperts and Execs Weigh In: Oncology Care in 2021 and Beyond
New Century Health recently convened health plan executives, industry experts and oncologists from across the nation to discuss the confluence of forces shaping oncology care in 2021 and beyond.
-
Read ArticleNew Century Health to Support Florida Blue Medicare with Comprehensive Oncology Management Services
The company will leverage New Century Health’s oncology specialty management program to help ensure its more than 125,000 Medicare Advantage members receive high-quality cancer care.
-
Watch VideoKey Forces Impacting Cancer Care: An Interview with Dr. Vinay Prasad
New Century Health's John Davis recently sat down with Dr. Prasad, author of "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer," to discuss key forces impacting cancer care.
-
Read External ArticleOncology Quickly Adapted for the Pandemic. Here are 5 Changes Worth Keeping
-
Read ArticleHow Real-World Evidence Can Transform High-Value Oncology Pathways
Our CMO Dr. Andrew Hertler explains how real world evidence may usher in the next generation of clinical oncology pathways.
-
Read ArticleHigh-Value Clinical Pathways Help Illinois Cancer Practice Reduce Drug Spend
Recent journal article details how NCH and Cancer Care Specialists of Illinois teamed up to slow growth in drug spend.
-
Read Press ReleaseNew Century Health Achieves NCQA Accreditation in Utilization Management
NCH also recertified by HITRUST® for patient privacy and data security protection.
-
Read ArticleNew Century Health Achieves NCQA Accreditation in Utilization Management
Specialty care management company also recertified by HITRUST® for patient privacy and data security protection.
-
Read ArticleDriving Culture Change in the Pursuit of Value: A Q&A with Cancer Care Specialists of Illinois
Dr. Mark Walshauser describes the impact of high-value oncology pathways and peer collaboration on his community practice.
-
Read External ArticleHow Clinical Pathways Are Growing
Increasing use of real-world evidence is one of the most exciting trends in pathway development, our CMO tells Journal of Clinical Pathways.
-
Read External ArticleClinical Pathways Slow Drug Spending in Community Oncology
Medscape delves into our work with a community oncology practice to implement high-value clinical pathways and engage providers
-
Watch VideoA Conversation with Swedish Cancer Institute's Dr. Jeffery Ward on COVID-19's Impact on Oncology
Dr. Jeffery Ward, an Oncologist / Hematologist with Swedish Cancer Institute, discusses the initial measures to protect patients, planning for the return of deferred care, and impact of COVID-19.
-
Loading More...
